Is Lisata Therapeutics, Inc. overvalued or undervalued?

Jun 25 2025 09:38 AM IST
share
Share Via
As of February 27, 2025, Lisata Therapeutics, Inc. is rated "risky" and considered overvalued, with a year-to-date return of -19.80%, significantly underperforming the S&P 500's 2.44% return.
As of 27 February 2025, Lisata Therapeutics, Inc. has moved from a grade of "does not qualify" to "risky." The company is currently considered overvalued. Key ratios include a Price to Book Value of 0.91, an EV to EBIT of 0.12, and an EV to EBITDA of 0.12. In comparison, Protara Therapeutics, Inc. has a valuation grade of "does not qualify" with an EV to EBITDA of 0.1010, while Cosmos Health, Inc. also carries a "risky" grade with an EV to EBITDA of -1.9265.

The company's recent performance has been poor, with a year-to-date return of -19.80%, significantly underperforming the S&P 500, which has returned 2.44% in the same period. This trend reinforces the valuation assessment, indicating that Lisata Therapeutics is currently overvalued in the market.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
What does Lisata Therapeutics, Inc. do?
Jun 22 2025 07:22 PM IST
share
Share Via
How big is Lisata Therapeutics, Inc.?
Jun 22 2025 06:32 PM IST
share
Share Via